title: Failure to detect vertical transmission of hepatitis C virus.
abstract: OBJECTIVE
  To search for transmission of hepatitis C virus (HCV) from infected mothers to their infants.
  
  
  METHODS
  Prospective clinical, serologic, and molecular biologic follow-up (at least 3 months) of the infants of mothers with anti-HCV antibody.
  
  
  METHODS
  A county hospital providing primary and referral care in high-risk obstetrics (perinatology).
  
  
  METHODS
  Twenty-three mothers with anti-HCV antibody and their 24 infants.
  
  
  METHODS
  An enzyme-linked immunosorbent assay (EIA) and a four-antigen recombinant immunoblot assay (RIBA) were used to test for anti-HCV antibody; serum HCV RNA was measured in two independent laboratories by reverse transcription and polymerase chain reaction (PCR) using nested primers in the 5'-noncoding region. Infant samples were tested for HCV RNA by PCR at delivery and after 3 to 6 months of follow-up. Each sample was tested at least four times in two independent laboratories.
  
  
  RESULTS
  Twenty-nine of 648 mothers (4.5%; 95% Cl, 3.0% to 6.4%) had anti-HCV antibody; these women had 30 babies. Twenty-three mothers and their 24 babies were followed at least 3 months (mean follow-up, 52 weeks). Of the 23 mothers, 21 (91%; Cl, 72% to 99%) had a reactive RIBA; one woman had an indeterminate RIBA and was positive for HCV RNA by PCR. In 16 of 23 mothers (70%; Cl, 47% to 87%), PCR yielded a positive result in both laboratories. The mean maternal alanine aminotransferase (ALT) level was 1.6 times the normal value. All the babies had anti-HCV antibody in cord-blood samples, but antibody disappeared or diminished in strength in interval samples, and no infant had evidence of active production of anti-HCV antibody. Only 1 of 24 (4%; Cl, 0.1% to 21%) cord-blood samples was HCV RNA positive, and none of 24 (0%; Cl, 0% to 14%) follow-up samples was positive for HCV RNA by PCR in either laboratory. Four mothers and one baby had antibody to HIV.
  
  
  CONCLUSIONS
  Infant anti-HCV antibody is most likely acquired passively in utero, and vertical transmission of HCV is uncommon.
authors.affiliation: Montefiore Medical Center, Division of Gastroenterology, Bronx, NY 10467.
authors.forename: J F
authors.initials: JF
authors.lastname: Reinus
authors.forename: E L
authors.initials: EL
authors.lastname: Leikin
authors.forename: H J
authors.initials: HJ
authors.lastname: Alter
authors.forename: L
authors.initials: L
authors.lastname: Cheung
authors.forename: M
authors.initials: M
authors.lastname: Shindo
authors.forename: B
authors.initials: B
authors.lastname: Jett
authors.forename: S
authors.initials: S
authors.lastname: Piazza
authors.forename: J W
authors.initials: JW
authors.lastname: Shih
mesh_terms: D005260:Female; D016174:Hepacivirus / Q000235:genetics / Q000276:immunology; D006508:Hepatitis Antibodies / Q000097:blood; D006526:Hepatitis C / Q000151:congenital* / Q000175:diagnosis / Q000635:transmission*; D006801:Humans; D007124:Immunoenzyme Techniques; D007231:Infant, Newborn; D016133:Polymerase Chain Reaction; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000175:diagnosis; D011446:Prospective Studies; D012367:RNA, Viral / Q000097:blood; D012698:Serologic Tests
chemical_list: D006508:Hepatitis Antibodies; D012367:RNA, Viral